R3TA
Current listing
R3TA - 30mg catalog listing for incretin and metabolic-signaling research.
Add to cart
Select quantity and add this listing to your order.
Research-use listing. For qualified laboratory research use only. No product-use instructions are provided.
In stock
Need BAC Water?
BAC Water is available for applicable laboratory orders and can also be ordered on its own.
Overview
R3TA is an investigational peptide studied for triple-receptor agonist activity across GLP-1, GIP, and glucagon receptor pathways.
Research interest centers on incretin signaling, glucose-homeostasis models, energy-expenditure pathways, hepatic lipid-metabolism endpoints, and comparative analysis against mono- or dual-agonist compounds.
Potential research applications
- GLP-1, GIP, and glucagon receptor signaling studies
- Central satiety-pathway and appetite-regulation research models
- Glucose-homeostasis, insulin-secretion, and beta-cell function studies
- Hepatic lipid-metabolism and energy-expenditure research
- Comparative mono-, dual-, and triple-agonist metabolic-model analysis
Research-use limits
For qualified laboratory research use only. This page does not provide protocols, product-use instructions, clinical guidance, outcome claims, or internal sourcing and batch details.
Order notes
Catalog listings can be added with quantity selection.
From the research library
ADA 2026: The Multi-Agonist and Oral Incretin Readouts, Summarized
ADA 2026 delivered phase 3 data on a triple GLP-1/GIP/glucagon agonist, a dual agonist, CagriSema and two oral agents. Here is the map.
Triple GLP-1/GIP/Glucagon Agonists: Where the Research Stands
How a single peptide came to activate three proglucagon-family receptors, what phase 2 trials of the class reported, and what is still unknown.
What Are GLP-1 Peptides? Incretin Biology for Researchers
The biology behind GLP-1: where it comes from, what it does, why the native hormone lasts two minutes, and how synthetic analogues were built to last a week.